Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior…

Overview of attention for article published in Journal of Clinical Oncology, May 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

policy: 1 policy source
twitter: 4 X users

f1000: 1 research highlight platform

Readers on

mendeley: 137 Mendeley

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 17,833 followers.

@DavisEnglund Here's an RCT, which I already sent to you. Downregulating mTOR delays tumor progression: http://t.co/YaQQXb30vJ

@DavisEnglund http://t.co/YaQQXb30vJ

Ridaforolimus (mTOR inhibitor) as maintenance therapy for metastatic soft tissue sarcoma: small improvement in PFS http://t.co/TcYG87Rkwa

Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin... http://t.co/is6Jr5ZBFB #pharmacy #health

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.